Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant.
Blood Adv
; 6(9): 2897-2907, 2022 05 10.
Article
in En
| MEDLINE
| ID: mdl-35108727
Full text:
1
Collection:
01-internacional
Health context:
4_TD
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Epstein-Barr Virus Infections
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Blood Adv
Year:
2022
Document type:
Article